Published in World J Emerg Surg on May 20, 2006
Washing red blood cells and platelets transfused in cardiac surgery reduces postoperative inflammation and number of transfusions: results of a prospective, randomized, controlled clinical trial. Pediatr Crit Care Med (2012) 1.67
Gender-specific differences in outcome after trauma may be explained by differences in immunity. Crit Care (2014) 1.06
Molecular mechanisms of inflammation and tissue injury after major trauma--is complement the "bad guy"? J Biomed Sci (2011) 1.04
Immunoinflammatory response in critically ill patients: severe sepsis and/or trauma. Mediators Inflamm (2013) 1.04
Temporal Patterns of Circulating Inflammation Biomarker Networks Differentiate Susceptibility to Nosocomial Infection Following Blunt Trauma in Humans. Ann Surg (2016) 1.03
Metabolic changes after polytrauma: an imperative for early nutritional support. World J Emerg Surg (2006) 1.02
Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2. Ann Surg (2007) 1.01
A systematic review of randomized controlled trials exploring the effect of immunomodulative interventions on infection, organ failure, and mortality in trauma patients. Crit Care (2010) 0.90
Acute alcohol intoxication reduces mortality, inflammatory responses and hepatic injury after haemorrhage and resuscitation in vivo. Br J Pharmacol (2012) 0.88
Proteomic profiling of the mesenteric lymph after hemorrhagic shock: Differential gel electrophoresis and mass spectrometry analysis. Clin Proteomics (2010) 0.87
Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study. Clin Exp Immunol (2011) 0.87
Plant polyphenols attenuate hepatic injury after hemorrhage/resuscitation by inhibition of apoptosis, oxidative stress, and inflammation via NF-kappaB in rats. Eur J Nutr (2011) 0.86
G-CSF drives a posttraumatic immune program that protects the host from infection. J Immunol (2014) 0.83
Myeloid knockout of HIF-1 α does not markedly affect hemorrhage/resuscitation-induced inflammation and hepatic injury. Mediators Inflamm (2014) 0.81
Subsequent gene expression pattern in dendritic cells following multiple trauma. Langenbecks Arch Surg (2012) 0.81
The diagnostic and prognostic value of systems biology research in major traumatic and thermal injury: a review. Burns Trauma (2016) 0.81
Trauma-associated human neutrophil alterations revealed by comparative proteomics profiling. Proteomics Clin Appl (2013) 0.80
The effect of C1-esterase inhibitor on systemic inflammation in trauma patients with a femur fracture - The CAESAR study: study protocol for a randomized controlled trial. Trials (2011) 0.79
Activation of NF-κB after chronic ethanol intake and haemorrhagic shock/resuscitation in mice. Br J Pharmacol (2013) 0.79
High-energy proximal femur fractures in geriatric patients: a retrospective analysis of short-term complications and in-hospital mortality in 32 consecutive patients. Geriatr Orthop Surg Rehabil (2011) 0.78
Immunophenotyping of posttraumatic neutrophils on a routine haematology analyser. Mediators Inflamm (2012) 0.77
Serum levels of HSP70 and other DAMP proteins can aid in patient diagnosis after traumatic injury. Cell Stress Chaperones (2016) 0.77
Xanthine oxidase injurious response in acute joint injury. Clin Chim Acta (2015) 0.77
Effects of Vitamin C or E on the Pro-inflammatory Cytokines, Heat Shock Protein 70 and Antioxidant Status in Broiler Chicks under Summer Conditions. Asian-Australas J Anim Sci (2014) 0.76
Predictive value of cytokines for developing complications after polytrauma. World J Crit Care Med (2016) 0.75
Intensive care organisation: Should there be a separate intensive care unit for critically injured patients? World J Crit Care Med (2015) 0.75
Reconciling the IPC and Two-Hit Models: Dissecting the Underlying Cellular and Molecular Mechanisms of Two Seemingly Opposing Frameworks. J Immunol Res (2015) 0.75
The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients. Daru (2014) 0.75
Probiotics for severe trauma patients. Crit Care (2011) 0.75
Review: Immunology of sinusitis, trauma, asthma, and sepsis. Allergy Rhinol (Providence) (2015) 0.75
HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 17.72
The danger model: a renewed sense of self. Science (2002) 13.85
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med (2004) 6.38
Proinflammatory cytokines. Chest (2000) 5.89
HMG-1 as a mediator of acute lung inflammation. J Immunol (2000) 4.78
'Damage control': an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma (1993) 4.63
Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med (2000) 3.89
Pathophysiology of polytrauma. Injury (2005) 3.33
Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med (1997) 2.98
Wound healing in the PU.1 null mouse--tissue repair is not dependent on inflammatory cells. Curr Biol (2003) 2.87
Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol (1987) 2.75
Postinjury multiple organ failure: a bimodal phenomenon. J Trauma (1996) 2.69
Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol (2002) 2.51
Wound healing: the role of the macrophage and other immune cells. Shock (1995) 2.26
The immunologic response to injury. J Am Coll Surg (2001) 2.20
Pitfalls in gastrointestinal permeability measurement in ICU patients with multiple organ failure using differential sugar absorption. Intensive Care Med (2001) 2.17
Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD11b. J Trauma (1998) 2.15
Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev (2003) 2.12
Neutrophil apoptosis pathways and their modifications in inflammation. Immunol Rev (2003) 2.08
Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit Care Med (2004) 1.90
Damage control: collective review. J Trauma (2000) 1.89
Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med (1996) 1.88
Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med (1998) 1.77
Multiple organ failure in trauma patients. J Trauma (2003) 1.66
Neutrophils use both shared and distinct mechanisms to adhere to selectins under static and flow conditions. J Clin Invest (1995) 1.63
Effect of oral antibiotics and bacterial overgrowth on the translocation of the GI tract microflora in burned rats. J Trauma (1985) 1.61
Regulation by C5a of neutrophil activation during sepsis. Immunity (2003) 1.54
Neutrophil priming: the cellular signals that say 'amber' but not 'green'. Immunol Today (1995) 1.51
Impact of intramedullary instrumentation versus damage control for femoral fractures on immunoinflammatory parameters: prospective randomized analysis by the EPOFF Study Group. J Trauma (2003) 1.46
Importance of increased intestinal permeability after multiple injuries. Eur J Surg (2001) 1.44
Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med (2000) 1.38
Postinjury neutrophil priming and activation: an early vulnerable window. Surgery (1995) 1.34
Injury research in the genomic era. Lancet (2004) 1.34
Stimulation of the inflammatory system by reamed and unreamed nailing of femoral fractures. An analysis of the second hit. J Bone Joint Surg Br (1999) 1.33
Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med (1995) 1.31
Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine (1990) 1.30
Appraisal of early evaluation of blunt chest trauma: development of a standardized scoring system for initial clinical decision making. J Trauma (2000) 1.25
Hmgb-1 as a therapeutic target for infectious and inflammatory disorders. Shock (2006) 1.25
Monitoring of neutrophil priming in whole blood by antibodies isolated from a synthetic phage antibody library. J Leukoc Biol (2000) 1.22
Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horiz (1996) 1.21
Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid Redox Signal (2002) 1.18
Lung cytokines and ARDS: Roger S. Mitchell Lecture. Chest (1999) 1.12
Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock (2003) 1.10
Adult respiratory distress syndrome, pneumonia, and mortality following thoracic injury and a femoral fracture treated either with intramedullary nailing with reaming or with a plate. A comparative study. J Bone Joint Surg Am (1997) 1.10
L-selectin in health and disease. Resuscitation (2002) 1.05
Science review: Cell membrane expression (connectivity) regulates neutrophil delivery, function and clearance. Crit Care (2003) 1.03
Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg (1992) 1.01
Bacterial lipoprotein delays apoptosis in human neutrophils through inhibition of caspase-3 activity: regulatory roles for CD14 and TLR-2. J Immunol (2004) 0.98
Insights from studies of blood substitutes in trauma. Shock (2005) 0.98
Reduced expression of neutrophil CD11b and CD16 after severe traumatic injury. J Surg Res (1992) 0.97
Circulating postinjury neutrophils are primed for the release of proinflammatory cytokines. J Trauma (1999) 0.97
Macrophage migration inhibitory factor. Crit Care Med (2005) 0.97
Soluble L-selectin levels predict survival in sepsis. Intensive Care Med (2002) 0.95
[Optimal duration of primary surgery with regards to a "Borderline"-situation in polytrauma patients. Arbeitsgemeinschaft "Polytrauma" der Deutschen Gesellschaft für Unfallchirurgie]. Unfallchirurg (1999) 0.94
Structural and biological stability of the human interleukin 10 homodimer. Biochemistry (1998) 0.92
C5 complement inhibition attenuates shock and acute lung injury in an experimental model of ruptured abdominal aortic aneurysm. Br J Surg (2005) 0.92
The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome. BMC Pulm Med (2004) 0.92
Cellular and molecular mechanisms of TNF protection in septic peritonitis. J Inflamm (1997) 0.91
Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis. J Trauma (1996) 0.91
Early inflammatory response correlates with the severity of injury. Crit Care Med (1996) 0.90
Initial recruitment of neutrophils to alveolar structures in acute lung injury. J Appl Physiol (1985) (1991) 0.90
Molecular events in neutrophil transepithelial migration. Bioessays (1997) 0.89
Characterization of circulating monocytes expressing HLA-DR or CD71 and related soluble factors for 2 weeks after severe, non-thermal injury. J Surg Res (2005) 0.89
Systemic and pulmonary effector cell function after injury. Crit Care Med (2002) 0.88
Priming, second-hit priming, and apoptosis in leukocytes from trauma patients. J Trauma (1999) 0.87
Whole blood tumor necrosis factor-alpha production and its relation to systemic concentrations of interleukin 4, interleukin 10, and transforming growth factor-beta1 in multiply injured blunt trauma victims. Crit Care Med (2000) 0.87
What is transforming growth factor-beta (TGF-beta)? Br J Plast Surg (2004) 0.86
Polymorphonuclear neutrophil chemiluminescence in whole blood from blunt trauma patients with multiple injuries. J Trauma (1999) 0.85
Posttraumatic complications and inflammatory mediators. Arch Surg (1986) 0.83
Assessment of immunological status in the critically ill. Minerva Anestesiol (2000) 0.82
Is macrophage migration inhibitory factor (MIF) the "control point" of vascular hypo-responsiveness in septic shock? Med Hypotheses (2005) 0.81
Neutrophil CD18 expression and blockade after traumatic shock and endotoxin challenge. Ann Surg (1994) 0.80
L-selectin: adhesion, signalling and its importance in pathologic posttraumatic endotoxemia and non-septic inflammation. Exp Toxicol Pathol (2005) 0.80
Trauma patients with positive cultures have higher levels of circulating macrophage migration inhibitory factor (MIF). Res Commun Mol Pathol Pharmacol (2000) 0.79
Ischemia-reperfusion directly increases pulmonary endothelial permeability in vitro. Shock (1999) 0.78
Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol (2000) 6.05
Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol (2000) 3.93
STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem (1996) 2.10
Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol (1995) 1.92
Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes. Mol Biol Cell (2001) 1.88
The 40-kDa Fc gamma receptor (FcRII) on human neutrophils is essential for the IgG-induced respiratory burst and IgG-induced phagocytosis. J Immunol (1989) 1.63
Eosinophil cationic protein and immunoglobulin levels in bronchoalveolar lavage fluid obtained from patients with chronic eosinophilic pneumonia. Eur Respir J (1996) 1.53
Eosinophil chemotactic activity in bronchoalveolar lavage from idiopathic pulmonary fibrosis is dependent on cytokine priming of eosinophils. Eur Respir J (1998) 1.48
Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal (1998) 1.42
The role of STATs in myeloid differentiation and leukemia. Oncogene (2000) 1.34
Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease. Clin Exp Immunol (2008) 1.30
STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells. Blood (1999) 1.29
Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl (2003) 1.28
STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells. Mol Cell Biol Res Commun (2000) 1.24
Relative contributions of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia. Blood (1993) 1.17
Platelet and fibrin deposition at the damaged vessel wall: cooperative substrates for neutrophil adhesion under flow conditions. Blood (1997) 1.17
Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. Biochem J (1998) 1.17
Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils. Thorax (2005) 1.16
RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood (1994) 1.11
Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood (1991) 1.11
Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways. Eur J Immunol (1991) 1.10
Regulation of p21rac activation in human neutrophils. Blood (1999) 1.09
Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family. Cytokine Growth Factor Rev (2001) 1.06
Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol (1993) 1.06
Activation of the STAT3/acute phase response factor transcription factor by interleukin-5. J Biol Chem (1995) 1.05
Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science (2001) 1.04
Continuous cell activation is necessary for stable interaction of complement receptor type 3 with its counter-structure in the aggregation response of human neutrophils. Eur J Immunol (1990) 1.03
Activation of the small GTPase rap1 in human neutrophils. Blood (1998) 1.01
Eosinophils do respond to fMLP. Blood (1987) 1.01
Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation. Arterioscler Thromb Vasc Biol (2003) 1.00
Analysis of signal transduction pathways in human eosinophils activated by chemoattractants and the T-helper 2-derived cytokines interleukin-4 and interleukin-5. Blood (1998) 0.99
In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood (1992) 0.98
The systemic inflammatory response induced by trauma is reflected by multiple phenotypes of blood neutrophils. Injury (2007) 0.98
Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics. Am J Respir Crit Care Med (1994) 0.98
Association of RACK1 and PKCbeta with the common beta-chain of the IL-5/IL-3/GM-CSF receptor. Oncogene (1999) 0.98
Neutrophil adhesion to fibrinogen and fibrin under flow conditions is diminished by activation and L-selectin shedding. Blood (1997) 0.97
Mechanisms involved in eosinophil migration. Platelet-activating factor-induced chemotaxis and interleukin-5-induced chemokinesis are mediated by different signals. J Leukoc Biol (1996) 0.95
Lineage-specific activation of STAT3 by interferon-gamma in human neutrophils. J Leukoc Biol (1999) 0.94
Activation of 12-O-tetradecanoylphorbol-13-acetate response element- and dyad symmetry element-dependent transcription by interleukin-5 is mediated by Jun N-terminal kinase/stress-activated protein kinase kinases. J Biol Chem (1997) 0.94
Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor. Oncogene (1999) 0.93
NADPH:O2 oxidoreductase of human eosinophils in the cell-free system. FEBS Lett (1990) 0.93
Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1 alpha. Blood (1995) 0.91
Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils. Pharmacol Res Commun (1986) 0.90
Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils. Eur Respir J (2010) 0.90
Cytokine-mediated cPLA(2) phosphorylation is regulated by multiple MAPK family members. FEBS Lett (2000) 0.89
Identification and characterization of CKLiK, a novel granulocyte Ca(++)/calmodulin-dependent kinase. Blood (2000) 0.89
Cytokine priming of the respiratory burst in human eosinophils is Ca2+ independent and accompanied by induction of tyrosine kinase activity. J Leukoc Biol (1993) 0.89
Human platelets secrete chemotactic activity for eosinophils. Blood (1993) 0.88
Platelet-dependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions. Blood (1996) 0.88
The role of transcription factor PU.1 in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene. Blood (1998) 0.88
P-selectin and MAC-1 mediate monocyte rolling and adhesion to ECM-bound platelets under flow conditions. J Leukoc Biol (1998) 0.88
Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol (1993) 0.87
Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes. J Allergy Clin Immunol (1993) 0.87
Characteristics of hexokinase, pyruvate kinase, and glucose-6-phosphate dehydrogenase during adult and neonatal reticulocyte maturation. Am J Hematol (1985) 0.86
Cloning and characterization of Fc alpha Rb, a novel Fc alpha receptor (CD89) isoform expressed in eosinophils and neutrophils. Blood (1996) 0.86
Analysis of signal transduction pathways regulating cytokine-mediated Fc receptor activation on human eosinophils. J Immunol (1998) 0.86
Tyrosine phosphorylation-dependent activation of phosphatidylinositide 3-kinase occurs upstream of Ca2+-signalling induced by Fcgamma receptor cross-linking in human neutrophils. Biochem J (1997) 0.86
Platelet associated fibrinogen and ICAM-2 induce firm adhesion of neutrophils under flow conditions. Thromb Haemost (1998) 0.86
C/EBP regulates the promoter of the eosinophil-derived neurotoxin/RNS2 gene in human eosinophilic cells. J Leukoc Biol (1999) 0.86
Characterization of eosinophil adhesion to TNF-alpha-activated endothelium under flow conditions: alpha 4 integrins mediate initial attachment, and E-selectin mediates rolling. J Immunol (1999) 0.86
Differential fMet-Leu-Phe- and platelet-activating factor-induced signaling toward Ral activation in primary human neutrophils. J Biol Chem (1999) 0.85
Platelet-activating factor (PAF) acts as an intercellular messenger in the changes of cytosolic free Ca2+ in human neutrophils induced by opsonized particles. FEBS Lett (1989) 0.85
Identification of cytokine-regulated genes in human leukocytes in vivo. J Allergy Clin Immunol (2000) 0.85
Down modulation of L-Selectin expression on eosinophils recovered from bronchoalveolar lavage fluid after allergen provocation. Clin Exp Allergy (1993) 0.85
Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4. J Invest Dermatol (1993) 0.84
NF-kappa B/Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells. Immunobiology (1997) 0.84
Biomarkers of therapy responsiveness in asthma: pitfalls and promises. Clin Exp Allergy (2011) 0.83
A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor beta c gene. J Immunol (1999) 0.83
Signal transduction in eosinophils. Clin Exp Allergy (1996) 0.83
Granulocyte signal transduction and priming: cause without effect? Immunol Lett (1997) 0.83
Differential mechanisms in the stimulus-secretion coupling in human basophils: evidence for a protein-kinase-C-dependent and a protein-kinase-C-independent route. Agents Actions (1990) 0.83
Activation of a functionally distinct 80-kDa STAT5 isoform by IL-5 and GM-CSF in human eosinophils and neutrophils. Mol Cell Biol Res Commun (1999) 0.83
Release of platelet-activating factor is important for the respiratory burst induced in human eosinophils by opsonized particles. Blood (1992) 0.82
Arachidonic acid can induce leukotriene C4 formation by purified human eosinophils in the absence of other stimuli. Biochem Biophys Res Commun (1988) 0.82
Insulin activates Stat3 independently of p21ras-ERK and PI-3K signal transduction. Oncogene (1997) 0.82
Epidermal growth factor and bombesin differ strikingly in the induction of early responses in Swiss 3T3 cells. J Cell Physiol (1990) 0.82
Cloning of T lymphocytes from bronchoalveolar lavage fluid. Am J Respir Cell Mol Biol (1992) 0.81
Acute-phase concentrations of soluble fibrinogen inhibit neutrophil adhesion under flow conditions in vitro through interactions with ICAM-1 and MAC-1 (CD11b/CD18). J Thromb Haemost (2013) 0.81
Cooperation between Fc gamma receptor II and complement receptor type 3 during activation of platelet-activating factor release by cytokine-primed human eosinophils. J Immunol (1994) 0.81
Differential activation of functionally distinct STAT5 proteins by IL-5 and GM-CSF during eosinophil and neutrophil differentiation from human CD34+ hematopoietic stem cells. Stem Cells (1998) 0.81
Bronchial and cutaneous responses in atopic dermatitis patients after allergen inhalation challenge. Clin Exp Allergy (1997) 0.81
Multiple tyrosine residues in the intracellular domain of the common beta subunit of the interleukin 5 receptor are involved in activation of STAT5. FEBS Lett (1997) 0.80
Cytokine-induced inside-out activation of FcalphaR (CD89) is mediated by a single serine residue (S263) in the intracellular domain of the receptor. Blood (2001) 0.80
Isolated blunt chest injury leads to transient activation of circulating neutrophils. Eur J Trauma Emerg Surg (2010) 0.80
Minimal platelet deposition and activation in models of injured vessel wall ensure optimal neutrophil adhesion under flow conditions. Arterioscler Thromb Vasc Biol (1999) 0.79
In vivo priming of FcalphaR functioning on eosinophils of allergic asthmatics. J Leukoc Biol (2000) 0.79
A novel syndrome of severe neutrophil dysfunction: unresponsiveness confined to chemotaxin-induced functions. Blood (1993) 0.79
C5a-induced migration of human monocytes is primed by dexamethasone. Am J Respir Cell Mol Biol (1995) 0.79
IL-8 induces a transient arrest of rolling eosinophils on human endothelial cells. J Immunol (2001) 0.78
Differential effects of the T helper cell type 2-derived cytokines IL-4 and IL-5 on ligand binding to IgG and IgA receptors expressed by human eosinophils. J Immunol (1997) 0.78
An AP-1 site in the promoter of the human IL-5R alpha gene is necessary for promoter activity in eosinophilic HL60 cells. FEBS Lett (1998) 0.78
Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics. Eur Respir J (1999) 0.77
A critical role for PI 3-kinase in cytokine-induced Fcalpha-receptor activation. Blood (2000) 0.77
Leukotriene C4 formation by purified human eosinophils can be induced by arachidonic acid in the absence of calcium-ionophore A23187. Agents Actions (1989) 0.77
Systemic eosinophil response induced by respiratory syncytial virus. Clin Exp Immunol (2006) 0.77
Cognate interaction between human lymphocytes and eosinophils is mediated by beta 2-integrins and very late antigen-4. J Lab Clin Med (1995) 0.76